Where our new drug targets come from
In the Cancer Research UK Cancer Therapeutics Unit, we use a number of approaches to identify new drug targets with novel mechanisms of action, including functional genomics or compound libraries that target protein degradation. In addition we use annotated chemical libraries to discover novel pathways in the context of cancer. Finally, we collaborate with basic scientists within the ICR, CRUK network, and beyond.